News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,150 Results
Type
Article (39821)
Company Profile (289)
Press Release (661040)
Section
Business (206424)
Career Advice (2019)
Deals (35728)
Drug Delivery (93)
Drug Development (82036)
Employer Resources (171)
FDA (16182)
Job Trends (14967)
News (348774)
Policy (32684)
Tag
Academia (2546)
Alliances (49983)
Alzheimer's disease (1323)
Approvals (16171)
Artificial intelligence (210)
Bankruptcy (357)
Best Places to Work (11738)
Biotechnology (206)
Breast cancer (231)
Cancer (1782)
Cardiovascular disease (135)
Career advice (1680)
CAR-T (128)
Cell therapy (371)
Clinical research (66229)
Collaboration (698)
Compensation (387)
COVID-19 (2578)
C-suite (175)
Data (1696)
Diabetes (221)
Diagnostics (6310)
Earnings (86582)
Employer resources (147)
Events (113230)
Executive appointments (589)
FDA (17128)
Funding (621)
Gene therapy (253)
GLP-1 (666)
Government (4378)
Healthcare (18831)
Infectious disease (2695)
Interviews (315)
IPO (16653)
Job creations (3674)
Job search strategy (1430)
Layoffs (444)
Legal (7917)
Lung cancer (259)
Manufacturing (243)
Medical device (13286)
Medtech (13291)
Mergers & acquisitions (19471)
Metabolic disorders (574)
Neuroscience (1747)
NextGen: Class of 2025 (6536)
Non-profit (4490)
Northern California (2193)
Obesity (315)
Opinion (196)
Patents (174)
People (57574)
Phase I (20652)
Phase II (29220)
Phase III (21642)
Pipeline (785)
Postmarket research (2569)
Preclinical (8719)
Radiopharmaceuticals (250)
Rare diseases (332)
Real estate (5986)
Regulatory (22146)
Research institute (2327)
Resumes & cover letters (349)
Southern California (1879)
Startups (3615)
United States (19357)
Vaccines (623)
Weight loss (215)
Date
Today (141)
Last 7 days (794)
Last 30 days (2754)
Last 365 days (34689)
2025 (5427)
2024 (35564)
2023 (40473)
2022 (51632)
2021 (56244)
2020 (54471)
2019 (46898)
2018 (35313)
2017 (32509)
2016 (31947)
2015 (38017)
2014 (31843)
2013 (26766)
2012 (28940)
2011 (29608)
2010 (27666)
Location
Africa (727)
Arizona (213)
Asia (38489)
Australia (6251)
California (5003)
Canada (1754)
China (422)
Colorado (229)
Connecticut (237)
Europe (83255)
Florida (741)
Georgia (171)
Illinois (465)
Indiana (272)
Japan (126)
Maryland (767)
Massachusetts (3820)
Michigan (200)
Minnesota (346)
New Jersey (1424)
New York (1427)
North Carolina (903)
Northern California (2193)
Ohio (174)
Pennsylvania (1133)
South America (1106)
Southern California (1879)
Texas (731)
Utah (153)
Washington State (482)
701,150 Results for "sienna biopharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.
December 30, 2024
·
11 min read
BioMidwest
Navidea Biopharmaceuticals, Inc. announces special meeting of stockholders to be held July 8, 2024
Navidea Biopharmaceuticals, Inc., a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced it will be hosting a virtual meeting of its stockholders at 1pm ET on Monday, July 8th, 2024.
June 20, 2024
·
5 min read
Business
Sienna Announces Third Quarter 2022 Results Release Date and Conference Call
Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) announced that it will report its 2022 third quarter results after market close on Wednesday, November 9, 2022.
October 14, 2022
·
1 min read
Press Releases
Seasoned Biopharmaceutical Industry Executives Teri Lawver and Jerry Durso Appointed to Altimmune Board of Directors
February 26, 2025
·
4 min read
Business
Sienna Announces First Quarter 2022 Results Release Date and Conference Call
Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) announced that it will report its 2022 first quarter results after market close on Thursday, May 12, 2022.
April 14, 2022
·
1 min read
Press Releases
Biopharmaceuticals Market Size Expected to Reach USD 1,796.21 Bn by 2034
February 17, 2025
·
1 min read
Deals
Eiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse Stock Split
Eiger BioPharmaceuticals, Inc. today announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-30.
January 4, 2024
·
5 min read
Press Releases
Alamar Biosciences Launches Certified Service Provider Program to Expand Access to NULISA technology for Academic and Biopharmaceutical Researchers
February 21, 2025
·
2 min read
Press Releases
Jupiter Neurosciences Partners with Zina Biopharmaceuticals to Advance Phase 2a Parkinson’s Trial
January 30, 2025
·
4 min read
Press Releases
Kangpu Biopharmaceuticals Received IND Approval from NMPA for KPG-818 to Treat Relapsed/Refractory Multiple Myeloma
February 26, 2025
·
1 min read
1 of 70,115
Next
